# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066231
Filing Date
2025-05-08
Accepted
2025-05-07 21:15:42
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-20250331.htm iXBRL | 10-Q | 1907638
2 | EX-10.1 | acad-ex10_1.htm | EX-10.1 | 49670
3 | EX-31.1 | acad-ex31_1.htm | EX-31.1 | 11730
4 | EX-31.2 | acad-ex31_2.htm | EX-31.2 | 11886
5 | EX-32.1 | acad-ex32_1.htm | EX-32.1 | 8525
6 | EX-32.2 | acad-ex32_2.htm | EX-32.2 | 8571
| Complete submission text file | 0000950170-25-066231.txt |  | 8094988

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acad-20250331.xsd | EX-101.SCH | 967191
71 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20250331_htm.xml | XML | 1523669

Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 25923479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)